Search results
Researchers reveal new cellular mechanical transducer
Phys.org· 2 days agoA research team has uncovered a novel regulator governing how cells respond to mechanical cues....
UC Berkeley opens civil rights investigation into backyard confrontation between a law professor and...
NBC NEWS· 1 week agoThe University of California, Berkeley, has opened a Title IX civil rights investigation into...
Rat Neurons Repair Mouse Brains That Lack a Sense of Smell
Scientific American· 2 weeks agoChimeras, fictional creatures made up of a combination of body parts from different animals, such as the mythological Minotaur, have captivated thinkers, philosophers and scientists throughout ...
Synchronisation between the central circadian clock and the circadian clocks of tissues preserves...
Newswise· 2 weeks agoBarcelona, 2 May 2024 - Discovered in the 1970s, circadian clocks are essential for the regulation of biological time in most cells in the human body. Circadian rhythms, which are coordinated ...
Prospects for Crohn's Relief Brighten With New Advancements
WebMD· 1 week agoMore than 1 million Americans live with Crohn’s, a chronic and sometimes crippling inflammatory...
Master regulator of inflammation found — and it's in the brain stem
Live Science via Yahoo News· 2 days agoResearch in mice suggests that specific neurons within the brainstem act like the dial on a...
Researcher discusses mechanism behind a birth defect affecting brain size
Medical Xpress· 2 weeks agoSika Zheng, a professor of biomedical sciences in the School of Medicine and the founding director of the Center for RNA Biology and Medicine at the University of ...
Anova to Manage Study of DB107 Following Newly Awarded $11.8M CIRM Grant
Benzinga· 2 weeks agoAnova to manage delivery of Phase 1/2a study of DB107 at UCSF, USC, UCSD and with Denovo Biopharma DB107 is a proprietary gene therapy platform for the treatment of patients with newly diagnosed high grade
Editas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoEditas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript May 8, 2024 Editas Medicine,...
Myelofibrosis: A Rare Malignancy Attracting More and More Attention
MedPage Today· 2 weeks agoMyelofibrosis remains a rare disease, even though recent attention to the condition might suggest...